Mobile

An Open-Label Extension Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects Ages 1 to <11 Years: A Long Term Study

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-001545-17

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To describe the long-term clinical experience of candesartan cilexetil in hypertensive children ages 1 to <11 years who have completed Protocol 328 (D2451C00002) and who have an ongoing clinical indication for treatment with candesartan cilexetil.

Critère d'inclusion

  • Hypertension in children in ages 1 to <11 years

Liens